What is the Vosoritide?

Vosoritide is , while it's Molecular Formula is C176H290N56O51S3. Used in Pharmaceutical Industry: Vosoritide is used as a therapeutic agent for the treatment of achondroplasia, aiming to improve the quality of life and overall growth of individuals with this condition. Its mechanism of action involves binding to the CNP receptor, which promotes bone growth, particularly in the long bones of the body. Used in Clinical Research: Vosoritide is used as a subject of investigation in clinical trials to assess its safety and efficacy in treating achondroplasia. The ongoing phase 3 clinical trial is crucial for determining whether vosoritide can be approved as a treatment option for this rare genetic disorder.

What is the CAS number for Vosoritide?

The CAS number of Vosoritide is 1480724-61-5.

What is Vosoritide (1480724-61-5) used for?

Vosoritide is a synthetic peptide analog of C-type natriuretic peptide (CNP) that is being investigated for its potential in treating achondroplasia, the most common form of short-limbed dwarfism. It functions by binding to the CNP receptor, which stimulates bone growth, especially in the long bones. Vosoritide has demonstrated promising results in early clinical trials, showing increased growth velocity and improved proportions in children with achondroplasia. It is currently undergoing a phase 3 clinical trial to further evaluate its safety and efficacy for this rare genetic disorder.

What is the Vosoritide?

Vosoritide is , while it's Molecular Formula is C176H290N56O51S3. Used in Pharmaceutical Industry: Vosoritide is used as a therapeutic agent for the treatment of achondroplasia, aiming to improve the quality of life and overall growth of individuals with this condition. Its mechanism of action involves binding to the CNP receptor, which promotes bone growth, particularly in the long bones of the body. Used in Clinical Research: Vosoritide is used as a subject of investigation in clinical trials to assess its safety and efficacy in treating achondroplasia. The ongoing phase 3 clinical trial is crucial for determining whether vosoritide can be approved as a treatment option for this rare genetic disorder.

What is the CAS number for Vosoritide?

The CAS number of Vosoritide is 1480724-61-5.

What is Vosoritide (1480724-61-5) used for?

Vosoritide is a synthetic peptide analog of C-type natriuretic peptide (CNP) that is being investigated for its potential in treating achondroplasia, the most common form of short-limbed dwarfism. It functions by binding to the CNP receptor, which stimulates bone growth, especially in the long bones. Vosoritide has demonstrated promising results in early clinical trials, showing increased growth velocity and improved proportions in children with achondroplasia. It is currently undergoing a phase 3 clinical trial to further evaluate its safety and efficacy for this rare genetic disorder.

Welcome to Hebei Zhaohe Chemical Technology Co., Ltd

+86 19003195139 +86 13722920871
admin@hb-sq.com

Language:English: 中文 English

 

Your Location：Home >Products >Pharmaceutical intermediates >1480724-61-5

1480724-61-5

Product NameVosoritide
Molecular FormulaC176H290N56O51S3
Molecular Weight4103
Purity99%

Inquiry

Product Details

Quick Details

CasNo： 1480724-61-5
Molecular Formula： C176H290N56O51S3
Purity： 99%

Perfect Factory Offer Excellent quality Vosoritide 1480724-61-5 with Safe Shipping

Molecular Formula:C176H290N56O51S3
Molecular Weight:4103

Relevant Products

Sodium poly[(naphthaleneformaldehyde)sulfonate]
CAS：9084-06-4
Rasburicase
CAS：134774-45-1
Copper tripeptide89030-95-5
CAS：89030-95-5
Triethanolamine
CAS：102-71-6

^*Product Name

CasNo

Quantity



Company Name

Phone

^*Email

^*Description

^*Code

Items marked with ^* are mandatory

Submit

Contact us

Address:Industrial Zone, Lincheng County, Xingtai City, Hebei Province

Phone:+86 19003195139 +86 13722920871

Email:admin@hb-sq.com

Maps

Home About us Products News Join Us Contact Us





Home

About us

Products

Pharmaceutical intermediates

Food Additives

Plant Extract

News

Join Us

Contact Us